We serve Chemical Name:N-(methoxymethyl)-1-(trifluoromethyl)cyclopropane-1-carboxamide CAS:1017789-65-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(methoxymethyl)-1-(trifluoromethyl)cyclopropane-1-carboxamide
CAS.NO:1017789-65-9
Synonyms:N-methoxymethyl-1-trifluoromethyl-cyclopropanecarboxylic acid amide
Molecular Formula:C7H10F3NO2
Molecular Weight:197.15500
HS Code:2924299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.82000
Exact Mass:197.06600
LogP:1.88930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-methoxymethyl-1-trifluoromethyl-cyclopropanecarboxylic acid amide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-methoxymethyl-1-trifluoromethyl-cyclopropanecarboxylic acid amide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-methoxymethyl-1-trifluoromethyl-cyclopropanecarboxylic acid amide Use and application,N-methoxymethyl-1-trifluoromethyl-cyclopropanecarboxylic acid amide technical grade,usp/ep/jp grade.
Related News: Dan Wygal, Country President for AstraZeneca Ireland, said: “I want to congratulate Charles River on their exciting plans to expand their Ballina site. Charles River is a long-standing strategic partner to AstraZeneca and have provided us with critical support in response to the pandemic. Proline, 5-oxo-4-[(triphenylmethyl)amino]-, cis- manufacturers The Japanese government plans to limit the administration of AstraZeneca’s vaccines to people aged 40 or over, according to the media. phosphoric acid 1-butylsulfanyl-2,2,2-trichloro-ethyl ester diethyl ester suppliers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 4-tert-butyl-N-[6-[6-[(4-tert-butylbenzoyl)amino]pyridin-2-yl]pyridin-2-yl]benzamide vendor & factory.
